These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 17627181

  • 1. No association of interleukin-6 gene polymorphism (-174 G/C) with premature coronary artery disease in a Turkish cohort.
    Sekuri C, Cam FS, Sagcan A, Ercan E, Tengiz I, Alioglu E, Berdeli A.
    Coron Artery Dis; 2007 Aug; 18(5):333-7. PubMed ID: 17627181
    [Abstract] [Full Text] [Related]

  • 2. Interleukin 6 G-174C polymorphism influences outcome following coronary revascularization surgery.
    Bittar MN, Carey JA, Barnard J, Fildes JE, Pravica V, Yonan N, Hutchinson IV.
    Heart Surg Forum; 2005 Aug; 8(3):E140-5; discussion E145. PubMed ID: 16183563
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The G894T polymorphism on endothelial nitric oxide synthase gene is associated with premature coronary artery disease in a Turkish population.
    Cam SF, Sekuri C, Tengiz I, Ercan E, Sagcan A, Akin M, Berdeli A.
    Thromb Res; 2005 Aug; 116(4):287-92. PubMed ID: 16038712
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A variant of beta fibrinogen is a genetic risk factor for coronary artery disease and myocardial infarction.
    Yu Q, Safavi F, Roberts R, Marian AJ.
    J Investig Med; 1996 Apr; 44(4):154-9. PubMed ID: 8689411
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Interleukin 18 gene promoter polymorphism: a link between hypertension and pre-hospital sudden cardiac death: the Helsinki Sudden Death Study.
    Hernesniemi JA, Karhunen PJ, Oksala N, Kähönen M, Levula M, Rontu R, Ilveskoski E, Kajander O, Goebeler S, Viiri LE, Hurme M, Lehtimäki T.
    Eur Heart J; 2009 Dec; 30(23):2939-46. PubMed ID: 19687159
    [Abstract] [Full Text] [Related]

  • 13. [Interleukin-6-597G/A and -572C/G polymorphisms and risk of coronary heart disease].
    Fu HX, Li GS, Li Y, Xu JL, Zhang JY.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jun; 34(6):519-22. PubMed ID: 16842669
    [Abstract] [Full Text] [Related]

  • 14. Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica.
    Boiardi L, Casali B, Farnetti E, Pipitone N, Nicoli D, Cantini F, Macchioni P, Bajocchi G, Catanoso MG, Pulsatelli L, Consonni D, Salvarani C.
    J Rheumatol; 2006 Apr; 33(4):703-8. PubMed ID: 16583473
    [Abstract] [Full Text] [Related]

  • 15. [Serum level and genotype of interleukin-6 in patients with esophageal cancer].
    Tang RG, Wei YS, Chen HM, Fang WZ, Long XK, Yuan XH.
    Zhonghua Yi Xue Za Zhi; 2007 Apr 24; 87(16):1126-8. PubMed ID: 17672997
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Synergistic effects of the polymorphisms in the PAI-1 and IL-6 genes with smoking in determining their associated risk with coronary artery disease.
    Sarecka B, Zak I, Krauze J.
    Clin Biochem; 2008 May 24; 41(7-8):467-73. PubMed ID: 18307986
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.